tiprankstipranks

Ma Songjiang Insider Profile

4 Followers
Ma Songjiang, President, Director at Gyre Therapeutics, holds 2.91M shares in Gyre Therapeutics (Ticker: GYRE).
tipranks
Ma Songjiang

Ma Songjiang
Gyre Therapeutics (GYRE)
President, Director

Not Ranked
Ma Songjiang has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$32M
100.00%
A breakdown of Ma Songjiang's holdings

Insider Roles

Gyre Therapeutics
(GYRE)
President, Director
Roles that Ma Songjiang holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Ma Songjiang

Ma Songjiang's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Gyre Therapeutics
Jan 16, 2025
President, Director
Uninformative Sell
42.48K
$31.88M
Ma Songjiang has not reported any informative transactions for GYRE, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 19, 2024
Uninformative Sell
$44.85K
-
$11.21
Dec 23, 2024
Uninformative Sell
$43.44K
-
$10.86
Dec 26, 2024
Uninformative Sell
$48.40K
-
$12.09
Dec 30, 2024
Uninformative Sell
$50.55K
-
$12.63
Jan 02, 2025
Uninformative Sell
$49.60K
-
$12.40
List of latest transactions for each holding click on a transaction to see Ma Songjiang's performance on stock

Ma Songjiang insider profile FAQ

What is the percentage of profitable transactions made by Ma Songjiang?
The percentage of profitable transactions made by Ma Songjiang is ―.
    What is the average return per transaction made by Ma Songjiang?
    The average return per transaction made by Ma Songjiang is ―.
      What stocks does Ma Songjiang hold?
      Ma Songjiang holds: GYRE stocks.
        What was Ma Songjiang’s latest transaction?
        Ma Songjiang latest transaction was an Uninformative Sell of $42.48K.
          What was Ma Songjiang's most profitable transaction?
          Ma Songjiang’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Ma Songjiang's role in Gyre Therapeutics?
            Ma Songjiang's role in Gyre Therapeutics is President, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.